preconception and prenatal options that can have a huge positive impact on the family. For example, Ashkenazi communities already use genetic screening to make lists of suitable marital partners early in life to avoid their offspring developing painful Tay-Sachs disease and dozens of similarly devastating diseases (which are not restricted to their community, by the way). Although we are tempted to restrict genomics to those with ethnic or family risks, the fact is that we are all at risk. Even the possibility of finding markers for one treatable disease (such as a cancer or cardiomyopathy) should be a sufficient reason to check one's genome.
Perhaps most provocatively, some critics assert that genomics could be harmful. The US Genetic Information Nondiscrimination Act (GINA) prevents genetics-based discrimination in health insurance and employment; however, there is not a GINA in every country, and it doesn't cover the military, life insurance or personto-person discrimination. But the question is: do the overall benefits of genomics exceed the risks? Do the benefits of driving trump the one-and-aquarter million traffic-related deaths per year? A growing number of bioethicists and researchers are worried that typical consenting practices do not inform patients of the likelihood of data escape and re-identification. Certainly, conventional consents served to protect the researchers, not the volunteers. However, the huge numbers of volunteers who are willing to share their genetic data make this a moot point. Why insist on recruiting those -and setting policy around those -who would be upset if their data escapes? In spite of, or because of, great progress in genomics, some people practise genetic modesty and do not wish to know what they can glean from their genetic details. Others will reject the opportunity, say, to reveal the genetic problems in store for loved ones such as children because they fear the social stigma that this could bring.
It is important for those of us at the sharp end of work on genomics to respect such views and not to judge those who hold them, but what about everybody else? We are not providing adequate and equal education about the risks and benefits of the genomic choices that are already available.
We already share our (very revealing) faces, voices and opinions. As we share more of our genetics, and as we develop genomic progress into precision medicine, researchers and the public alike need frank assessments of all these tests and treatments. We need the X Prize more than ever. ■ 
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